TL;DR: A 2026 Phase I study in CNS Drugs found that a 400 mg powdered cannabidiol (CBD) formulation reached peak blood levels faster than oil-based Epidyolex, especially after a high-fat meal, while both products were generally well tolerated in healthy adults. Key Findings Four-way crossover trial: Researchers gave 32 healthy adults single 400 mg doses …
TL;DR: A 2026 medRxiv preprint applied the AT(N) framework, an Alzheimer’s disease biomarker system for amyloid, tau, and neurodegeneration, to 84 older adults with focal epilepsy and found that only 32.1% had normal blood biomarkers, while early-onset epilepsy carried higher odds of biomarker abnormality. Key Findings Epilepsy cohort: Researchers analyzed focal epilepsy participants from the …
Astrocyte BMP Suppression Eased Fragile X Signals TL;DR: In a fragile X mouse model, suppressing BMP signaling specifically in astrocytes reduced sound-triggered seizure severity and partially restored synaptic activity in the auditory cortex, a sound-processing region relevant to sensory over-responsiveness. Key Findings BMP signaling was elevated in fragile X astrocytes: The study focused on bone …
Gut microbiota may influence epilepsy, but the exact mechanisms and involved microbiota are unclear, with potential treatments including ketogenic diets, probiotics, and fecal microbiota transplants being explored. Highlights: Approximately 33% of epilepsy patients are resistant to all antiseizure medications, with the role of gut microbiota in epilepsy being increasingly evident. The gut-brain axis, involving neuroendocrine, …
Epilepsy impacts millions of people worldwide. While medications have been the mainstay of treatment, one-third of patients continue to have seizures despite available drugs. This highlights the need for innovative therapies. Recent years have seen exciting developments that bring new promise for improved seizure control. Key Facts: Epilepsy is a neurological disorder characterized by recurrent, …
